Fluoroestradiol F18

(Cerianna®)

Cerianna®

Drug updated on 11/14/2023

Dosage FormInjection (intravenous;148 MBq/mL to 3,700 MBq/mL)
Drug ClassRadioactive diagnostic agents
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • Indicated for use with positron emission tomography (PET) imaging for the detection of estrogen receptor (ER)-positive lesions as an adjunct to biopsy in patients with recurrent or metastatic breast cancer.

Product Monograph / Prescribing Information

Document TitleYearSource
Cerianna (fluoroestradiol F18) Prescribing Information.2022GE Healthcare, Wauwatosa, WI

Systematic Reviews / Meta-Analyses